NIH-Funding

Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01 Clinical Trial Optional)

NIH Funding Announcements - Thu, 11/02/2017 - 09:48
Funding Opportunity PA-18-003 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages collaborative applications that will contribute to the identification and characterization of patients at risk of developing cancer treatment-related cardiotoxicity. The primary intent is to mitigate cardiovascular dysfunction while optimizing cancer outcomes. To accomplish this, methods that evaluate cardiac risk prior to treatment and integrate evidence-based cancer treatment regimens with screening, diagnostic, and/or management strategies are sought. Research applications should focus on mitigation/management of adverse effects associated with anti-cancer treatments including: cytotoxic chemotherapies, targeted agents, immunomodulatory therapies and radiation (that occur during cancer treatment and/or long-term survivorship) as defined by cardiac specific common terminology criteria for adverse events (CTCAE).
Categories: NIH-Funding

Examination of Survivorship Care Planning Efficacy and Impact (R01 Clinical Trial Optional)

NIH Funding Announcements - Thu, 11/02/2017 - 09:45
Funding Opportunity PA-18-002 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to stimulate research evaluating the effect of care planning on self-management of late effects of cancer therapy; adherence to medications, cancer screening, and health behavior guidelines; utilization of follow-up care; survivors' health and psychosocial outcomes. How organizational-level factors influence the implementation of care planning and its associated costs is also of interest. Specifically, the FOA aims to stimulate research that will: 1) develop and test metrics for evaluating the impact of survivorship care planning; 2) evaluate the impact of survivorship care planning on cancer survivors' morbidity, self-management and adherence to care recommendations, utilization of follow-up care; 3) evaluate effects of planning on systems outcomes, such as associated costs and impact on providers and organizations implementing the care planning; and 4) identify models and processes of care that promote effective survivorship care planning. The ultimate goal of this FOA is to generate a body of science that will inform the development and delivery of interventions that improve follow-up care for cancer survivors.
Categories: NIH-Funding

Revision Applications for Validation of Mobile/Wireless Health Tools for Measurement and Intervention (R01) (Clinical Trials Not Allowed)

NIH Funding Announcements - Thu, 11/02/2017 - 09:31
Funding Opportunity PA-18-338 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites revision applications from investigators and institutions/organizations with active NIH-supported research project awards to support an expansion of the scope of approved and funded projects to incorporate recent advances in mobile/wireless tools to validate these tools for measurement and intervention delivery. Revision applications for projects that do not currently employ mobile/wireless tools are welcome provided that the applicant team has the requisite scientific and technical expertise to employ and validate these tools.
Categories: NIH-Funding

Revision Applications for Validation of Mobile/Wireless Health Tools for Measurement and Intervention (R01) Clinical Trial Optional

NIH Funding Announcements - Thu, 11/02/2017 - 09:31
Funding Opportunity PA-18-339 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites revision applications from investigators and institutions/organizations with active NIH-supported research project awards to support an expansion of the scope of approved and funded projects to incorporate recent advances in mobile/wireless tools to validate these tools for measurement and intervention delivery. Revision applications for projects that do not currently employ mobile/wireless tools are welcome provided that the applicant team has the requisite scientific and technical expertise to employ and validate these tools.
Categories: NIH-Funding

Reminder: FORMS-E Grant Application Forms and Instructions Must be Used for Due Dates On or After January 25, 2018

NIH Funding Announcements - Thu, 11/02/2017 - 03:57
Notice NOT-HS-18-003 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

NCI Research Specialist (Laboratory-based Scientist) Award (R50)

NIH Funding Announcements - Thu, 11/02/2017 - 03:07
Funding Opportunity PAR-18-341 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites grant applications for the Research Specialist Award (R50) in any area of NCI-funded cancer research. This FOA is specifically for laboratory-based scientists.
Categories: NIH-Funding

NCI Research Specialist (Core-based Scientist) Award (R50)

NIH Funding Announcements - Thu, 11/02/2017 - 03:07
Funding Opportunity PAR-18-342 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites grant applications for the Research Specialist Award (R50) in any area of NCI-funded cancer research. This FOA is specifically for core/shared resource/central scientific support scientists.
Categories: NIH-Funding

Closing April 2018 Application Receipt Date for PAR-14-246 NIOSH Support for Conferences and Scientific Meetings (R13)

NIH Funding Announcements - Thu, 11/02/2017 - 02:10
Notice NOT-OH-18-003 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

Closing April 2018 Application Receipt Date for PAR-14-229 NIOSH Support for Conferences and Scientific Meetings (U13)

NIH Funding Announcements - Thu, 11/02/2017 - 02:05
Notice NOT-OH-18-002 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

By: Mrama

WriteEdit-Grant Questions Blog - Wed, 11/01/2017 - 21:09

Hi writedit
I have been a long time follower of your wonderful blog, it has helped me through successful a F32 and a K22. I just got my score for my first R01. It went to NIGMS, and received and impact score of 28, 12th percentile. I am a new investigator but not eligible for ESI. Can I feel cautiously optimistic?I’d love to hear your thoughts. Thank you!

Categories: NIH-Funding

NIA Program Project Applications (P01 Clinical Trial Optional)

NIH Funding Announcements - Wed, 11/01/2017 - 11:29
Funding Opportunity PAR-18-297 from the NIH Guide for Grants and Contracts. The National Institute on Aging invites the submission of investigator-initiated program project (P01) applications. The applications should address scientific areas relevant to the NIA mission. Each application submitted to this FOA must include at least three related research projects that share a common central theme, focus, and/overall objective and an administrative core to lead the project.
Categories: NIH-Funding

Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)

NIH Funding Announcements - Wed, 11/01/2017 - 11:24
Funding Opportunity PAR-18-296 from the NIH Guide for Grants and Contracts. This FOA allows for applications that propose large-scale, complex research projects with multiple highly integrated components focused on a common research question relevant to aging. Such projects will likely involve an integrated multidisciplinary team of investigators within a single institution or a consortium of institutions.
Categories: NIH-Funding

Pilot Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01 Clinical Trial Optional)

NIH Funding Announcements - Wed, 11/01/2017 - 11:17
Funding Opportunity PAR-18-175 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications that propose to develop and implement Phase I or II clinical trials of promising pharmacological and non-pharmacological interventions in individuals with age-related cognitive decline and in individuals with Alzheimer's disease (AD) across the spectrum from pre-symptomatic to more severe stages of disease, as well as to stimulate studies to enhance trial design and methods.
Categories: NIH-Funding

Maternal Nutrition and Pre-pregnancy Obesity: Effects on Mothers, Infants and Children (R01 Clinical Trial Optional)

NIH Funding Announcements - Wed, 11/01/2017 - 11:14
Funding Opportunity PA-18-135 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications to improve health outcomes for women, infants and children, by stimulating interdisciplinary research focused on maternal nutrition and pre-pregnancy obesity. Maternal health significantly impacts not only the mother but also the intrauterine environment, and subsequently fetal development and the health of the newborn.
Categories: NIH-Funding

Increasing the Use of Medications for the Treatment of Alcohol Use Disorders (R01 Clinical Trial Optional)

NIH Funding Announcements - Wed, 11/01/2017 - 11:12
Funding Opportunity PAR-18-196 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages health services research designed to increase the public health impact of Food and Drug Administration (FDA)-approved pharmacotherapies for the treatment of alcohol use disorder. Significant progress is needed in developing generalizable, scalable, cost-effective strategies to move these evidence-based interventions into the mainstream of alcohol use disorder treatment, in both general medical and specialty care settings. The National Institute on Alcohol Abuse and Alcoholism (NIAAA) seeks applications to conduct hypothesis-driven research to identify effective methods for increasing the utilization of currently-available medications, by addressing their acceptability (to prescribers and patients), perceived effectiveness, affordability, and feasibility of use within existing care delivery systems.
Categories: NIH-Funding

Program for Extramural/Intramural Alcohol Research Collaborations (U01 Clinical Trial Optional)

NIH Funding Announcements - Wed, 11/01/2017 - 11:10
Funding Opportunity PAR-18-195 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity is to encourage collaboration between alcohol researchers in the extramural community and those within the NIAAA intramural research program. The objective of this Funding Opportunity Announcement is to bring together the research expertise that, as a functioning collaborative unit, will address key alcohol-based research questions that would not otherwise be possible by the same individuals working towards similar goals in isolation. The goal of the research proposed by the collaborating investigators should address questions that advance the alcohol research field with respect to issues surrounding alcohol use disorders including dependence and the effects of alcohol on health. The NIH Intramural Scientist will be a tenured or tenure-track scientist from the NIAAA Intramural Research Program, with whom the PD/PI has made prior contact for the collaborative project.
Categories: NIH-Funding

Addressing Health Disparities through Effective Interventions Among Immigrant Populations (R21 Clinical Trial Optional)

NIH Funding Announcements - Wed, 11/01/2017 - 11:08
Funding Opportunity PA-18-285 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support and accelerate innovative exploratory and developmental research to develop and test feasibility of effective interventions to address health disparities among U.S. immigrant populations.
Categories: NIH-Funding

Addressing Health Disparities through Effective Interventions Among Immigrant Populations (R01 Clinical Trial Optional)

NIH Funding Announcements - Wed, 11/01/2017 - 11:05
Funding Opportunity PA-18-284 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support innovative research to develop and implement effective interventions to address health disparities among U.S. immigrant populations.
Categories: NIH-Funding

Alcohol Impairment of Immune Function, Host Defense and Tissue Homeostasis (R01 Clinical Trial Optional)

NIH Funding Announcements - Wed, 11/01/2017 - 11:02
Funding Opportunity PA-18-191 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications from researchers with broad expertise to study the consequences of alcohol consumption on immune function with a goal toward improving the outcome of patients who abuse alcohol.
Categories: NIH-Funding